(Q42984427)

12 November 2017

title

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin (English)

1 reference

12 November 2017

1 reference

1 reference

6

1 reference

12 November 2017

5

Maria Stepanova

1 reference

12 November 2017

Zobair M Younossi

1

1 reference

12 November 2017

Ancha Baranova

2

1 reference

12 November 2017

Arian Afendy

3

1 reference

12 November 2017

Rochelle Collantes

4

1 reference

12 November 2017

Anita Bakshi

7

1 reference

12 November 2017

Christopher L Sigua

8

1 reference

12 November 2017

Joanne P Chan

9

1 reference

12 November 2017

Ayuko A Iverson

10

1 reference

12 November 2017

Christopher D Santini

11

1 reference

12 November 2017

Sheng-Yung P Chang

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

12 November 2017

1 reference

12 November 2017

volume

49

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

763-774

1 reference

Epidemiology of hepatitis C virus infection

12 November 2017

cites work

1 reference

Update on viral hepatitis: 2006.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Chronic hepatitis C virus infection: genotyping and its clinical role

21 January 2018

1 reference

Optimizing treatment regimens in hepatitis C.

21 January 2018

1 reference

Sequence diversity of hepatitis C virus: implications for immune control and therapy

21 January 2018

1 reference

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

21 January 2018

1 reference

Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection

21 January 2018

1 reference

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence

21 January 2018

1 reference

Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.

21 January 2018

1 reference

Prospective study on early virologic response to treatment with interferon alpha-2b plus ribavirin in patients with chronic hepatitis C genotype 1b.

21 January 2018

1 reference

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

21 January 2018

1 reference

Treatment of chronic hepatitis C in nonresponders to previous therapy

21 January 2018

1 reference

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

21 January 2018

1 reference

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies

21 January 2018

1 reference

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

21 January 2018

1 reference

Microarray technology in the study of obesity and non-alcoholic fatty liver disease

21 January 2018

1 reference

The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease

21 January 2018

1 reference

Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?

21 January 2018

1 reference

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays

21 January 2018

1 reference

Integrated expressional analysis: application to the drug discovery process.

21 January 2018

1 reference

Scalable transcriptional analysis routine--multiplexed quantitative real-time polymerase chain reaction platform for gene expression analysis and molecular diagnostics

21 January 2018

1 reference

Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions

21 January 2018

1 reference

Transcript imaging of the development of human T helper cells using oligonucleotide arrays

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

Economics of chronic hepatitis B and hepatitis C.

21 January 2018

1 reference

HCV findings presented at EASL: long-term follow-up and the criteria of a cure

21 January 2018

1 reference

Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy

21 January 2018

1 reference

Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.

21 January 2018

1 reference

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.

21 January 2018

1 reference

T cell response in hepatitis C virus infection

21 January 2018

1 reference

The immunopathogenesis of hepatitis C virus infection

21 January 2018

1 reference

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy

21 January 2018

1 reference

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.22729

1 reference

12 November 2017

1 reference